Jan 5, 2018
Top Pharma News of the Week
U.S. FDA Approves Pfizer’s Bosulif® (Bosutinib) For the Treatment of Patients with Newly-Diagnosed Ph+ Chronic Myelogenous Leukemia (CML)
December 19, 2017
Pfizer Inc. has announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) to expand the indication for BOSULIF® (bosutinib) to include adult patients with newly-diagnosed chronic phase…
View On WordPress